Two Decades After BRCA: Setting Paradigms in Personalized Cancer Care and Prevention
Top Cited Papers
- 28 March 2014
- journal article
- perspective
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 343 (6178), 1466-1470
- https://doi.org/10.1126/science.1251827
Abstract
The cloning of the breast cancer susceptibility genes BRCA1 and BRCA2 nearly two decades ago helped set in motion an avalanche of research exploring how genomic information can be optimally applied to identify and clinically care for individuals with a high risk of developing cancer. Genetic testing for mutations in BRCA1 , BRCA2 , and other breast cancer susceptibility genes has since proved to be a valuable tool for determining eligibility for enhanced screening and prevention strategies, as well as for identifying patients most likely to benefit from a targeted therapy. Here, we discuss the landscape of inherited mutations and sequence variants in BRCA1 and BRCA2 , the complexities of determining disease risk when the pathogenicity of sequence variants is uncertain, and current strategies for clinical management of women who carry BRCA1/2 mutations.Keywords
This publication has 95 references indexed in Scilit:
- Clinical significance of large rearrangements in BRCA1 and BRCA2Cancer, 2012
- A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor–negative breast cancerNature Genetics, 2011
- A review of a multifactorial probability-based model for classification of BRCA1 and BRCA2 variants of uncertain significance (VUS)Human Mutation, 2011
- Tumor suppressor BRCA1 epigenetically controls oncogenic microRNA-155Nature Medicine, 2011
- Personalized medicine: new genomics, old lessonsHuman Genetics, 2011
- Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and MortalityJAMA, 2010
- International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriersInternational Journal of Cancer, 2008
- PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility geneNature Genetics, 2006
- Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2Nature Genetics, 1996
- Identification of the breast cancer susceptibility gene BRCA2Nature, 1995